SCHEMBL7440657

SCHEMBL7440657

CCc1ccc(F)c(NC(=N)Nc2cccc3ccccc23)c1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
GAA P10253 2/20 0.53
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
TAOK1 Q7L7X3 1/20 0.45
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
EPHX1 P07099 1/20 0.43
TRPV1 Q8NER1 1/20 0.42
SIGMAR1 Q99720 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2A6 P11509 1/20 0.41
KDM4E B2RXH2 3/20 0.41
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GSK3B P49841 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7204915 0.99 MEN1 (0.53) MEN1KMT2AGAANPC1RAB9A
SCHEMBL6716812 0.84 GAA (0.53) MEN1KMT2AGAATAOK1ALDH1A1
SCHEMBL6717072 0.84 GAA (0.53) MEN1KMT2AGAANPC1RAB9A
Hydrochloric Acid SCHEMBL7203893 0.83 GAA (0.52) MEN1KMT2AGAATAOK1ALDH1A1
Hydrochloric Acid SCHEMBL7208617 0.83 GAA (0.52) MEN1KMT2AGAANPC1RAB9A
SCHEMBL6724021 0.82 KMT2A (0.78) MEN1KMT2AGAANPC1RAB9A
SCHEMBL6724526 0.82 ALDH1A1 (0.56) MEN1KMT2AGAAALDH1A1HPGD
SCHEMBL6720741 0.82 GAA (0.48) MEN1KMT2AGAANPC1RAB9A
SCHEMBL6724583 0.81 GAA (0.46) KMT2AGAAALDH1A1HPGDSIGMAR1
Hydrochloric Acid SCHEMBL7203895 0.81 KMT2A (0.76) MEN1KMT2AGAANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999002145-A1 COMBINATION DRUG THERAPIES COMPRISING AMINOGLYCOSIDE ANTIBIOTICS AND N,N'-DISUBSTITUTED GUANIDINES CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-01-21 WO claimed
EP-0705100-A4 THERAPEUTIC SUBSTITUTED GUANIDINES CAMBRIDGE NEUROSCIENCE INC (US) 1996-05-29 EP claimed
EP-0705100-A1 THERAPEUTIC SUBSTITUTED GUANIDINES CAMBRIDGE NEUROSCIENCE, INC. (US) 1996-04-10 EP claimed
WO-1994027591-A1 THERAPEUTIC SUBSTITUTED GUANIDINES CAMBRIDGE NEUROSCIENCE, INC. (US) 1994-12-08 WO claimed